Skip to Main Content

Paper Details

A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
Nat Commun
44
2021
Author NameAffiliation
Dong LinBC Cancer Research Centre
Ladan FazliBC Cancer Research Centre
R Jeffrey KarnesMayo Clinic College of Medicine and Science
Liewei WangMayo Clinic College of Medicine and Science
Martin E GleaveUniversity of British Columbia
Yuzhuo WangBC Cancer Research Centre
Yuzhuo WangUniversity of British Columbia
  • 1 - 7

Datasets

Release 1.2